Summit will explore policies impacting patient access to biologic and biosimilar medications
WASHINGTON – Tomorrow the Institute for Patient Access and Biologics Prescribers Collaborative, a project of the Alliance for Patient Access, will host the 2nd Annual National Policy and Advocacy Summit on Biologics and Biosimilars in Washington, DC. The summit will explore timely state and federal policy issues impacting patient access to approved biologic therapies and their biosimilar counterparts. The summit, held at the Ronald Reagan Building and International Trade Center, will feature remarks by Senator Bill Cassidy, M.D. (R-La.), FDA official Leah Christl, Ph.D, and Shannon Miller, decorated Olympic gymnast and cancer survivor. The summit is open to the press. Press interested in attending should RSVP to Susan Hepworth at [email protected].
WHO: Health care providers, patient advocates and representatives from national physician associations
WHAT: 2nd Annual National Policy and Advocacy Summit on Biologics and Biosimilars
WHERE: Ronald Reagan Building and International Trade Center – Rotunda Room
1300 Pennsylvania Avenue NW
WHEN: Thursday, April 6, 9:15 a.m. to 2:45 p.m.
Biologics Prescribers Collaborative http://biologicsprescribers.org
Alliance for Patient Access http://allianceforpatientaccess.org